title: Research outcomes and recommendations for the assessment of progression in cancer clinical trials.
authors: AstraZeneca Pharmaceuticals LP, Wilmington, Delaware 19850 , USA. william.bushnell@astrazeneca.com
authors: Will
authors: W
authors: Bushnell
authors: Andrew
authors: A
authors: Stone
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic / Q000379:methods / Q000706:statistics & numerical data*; D018572:Disease-Free Survival; D006801:Humans; D009369:Neoplasms / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology*; D012107:Research Design / Q000592:standards / Q000639:trends; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents